1 / 17

Identifying Keratinocyte Derived Collagen Inhibitory Factors to Treat Hypertrophic Scar and Keloid

Identifying Keratinocyte Derived Collagen Inhibitory Factors to Treat Hypertrophic Scar and Keloid. By: Ali Farrokhi (PhD student) Supervisor: Dr. Ghahary 25 Jun 2014. Introduction. The history of wound healing is, in a sense, the history of humankind.

ethanael-nathan
Download Presentation

Identifying Keratinocyte Derived Collagen Inhibitory Factors to Treat Hypertrophic Scar and Keloid

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Identifying Keratinocyte Derived Collagen Inhibitory Factors to Treat Hypertrophic Scar and Keloid By: Ali Farrokhi (PhD student) Supervisor: Dr. Ghahary 25 Jun 2014

  2. Introduction • The history of wound healing is, in a sense, the history of humankind. • One of the oldest medical manuscripts known to man is a clay tablet that dates back to 2200 B.C, describes the “three healing gestures”—washing the wounds, making the plasters, and bandaging the wound. wound healing over-healing non-healing

  3. Problem: Hypertrophic scar and Keloid Over healing such as post-burn hypertrophic scarring (HSc) and keloid are disfiguring and devastating, resulting in bulky, itchy and inelastic scars that pose serious functional and cosmetic problems for recovering burn patients. Fibrosis: • Cirrhosis (liver), • Endomyocardialfibrosis (heart) • - Myelofibrosis(bone marrow) • - Crohn'sDisease (intestine) • - Old myocardial infarction (heart) • - Scleroderma/systemic sclerosis (skin, lungs) Wound Keratinocytes Epidermis Collagen fibers Fibroblasts Dermis

  4. Hypothesis and Objectives • Upon wound epithelialization, keratinocytes release two sets ofECM regulating factors: • The 1st set: stimulate the expression of Matrix Metalo-Proteinase (MMP-1, 3) • The 2nd set: suppresses the expression of key ECM components like type I and III collagen. • To test this hypothesis, we propose the following Specific Objectives: • Objective 1. Identify and characterize Keratinocyte Derived Collagen Inhibitory Factors (KD-CIF) for fibroblasts • Objective 2. Reveal the mechanism for inhibition of type 1 collagen production by KD-CIF

  5. Overall Procedure • Identifying factors in KCM which are involved in extracellular matrix regulation (ECM) • Finding out the mechanism of ECM regulation by KCM

  6. Keratinocytes Conditioned Media (KCM) inhibits collagen type 1 production in fibroblasts. Western blot analysis of intracellular proteins showed the inhibition of Collagen type 1 synthesis in time dependent manner. D0, Cnt 12h 24h 36 h 48h 60h 72h 72 h, Cnt KCM treated fibroblasts Control Fibroblast pro-collagen1 B-actin

  7. Collagen Inhibitory Factor (CIF) is released from undifferentiated proliferating keratinocytes. d0, Confluent -2 d Control +2 d, diff +6 d, diff +4d, diff +8 d, diff Fibroblasts culture Pro-Coll ACTB KRT 14 Keratinocytes Conditioned Media KRT 10 Involucrin +d4 +d8 -2 d +d6 d0 +d2 Tbp Keratinocytes culture Keratinocytes For RT-PCR and Western Blot Involucrin -2 d +2 d, diff +6 d, diff +4d, diff Confluent +8 d, diff ACTB

  8. Keratinocytes Conditioned Media (KCM) inhibits collagen type 1 production in fibroblasts. Western blot analysis of intracellular proteins showed the inhibition of Collagen type 1 synthesis in time dependent manner. A D0, Cnt 12h 24h 36 h 48h 60h 72h D3, Cnt KCM inhibits collagen type 1 expression post-transcriptionally. After treatment of fibroblasts with KCM, cells were harvested at different time points to evaluate Col1a1 (A) and Col1a2 (B) genes expression by qRT-PCR. B pro-collagen1 B-actin

  9. Post- Transcriptional regulation: - Evaluation of Collagen type 1 mRNA Stability Col1a1 Col1a2 6 hr- Control 12 hr- Control 6 hr- Control+ DRB 6 hr- KCM+ DRB 6 hr- Control 12hr- Control+ DRB 12hr- KCM+ DRB 12 hr- Control 6 hr- Control+ DRB 6 hr- KCM+ DRB 12 hr- Control+ DRB 12hr- KCM+ DRB - Cytoplasmic Vs Nuclear RNA Col1a1 Col1a2 NucKCM Nuc- Control Cyto- control Cyto- KCM NucKCM Cyto- control Nuc- Control Cyto- KCM

  10. At least two sets of factors cooperate to inhibit Collagen production KCM KCM KCM > 9 KD retentate >30 KD > 50 KD < 50KD filterate > 30 KD < 9KD

  11. Fast protein liquid chromatography F5 F7 F9 F11 F13 F15 F17 F17 F21 F23 KCM pro-collagen1 B-actin Size Exclusion Chromatography Apparatus

  12. Future Plan • Find out which step of post-transcriptional regulation is involved in Collagen type 1 regulation by KCM • Which specific factors are in KCM that do Collagen production inhibition

  13. Thanks to … • Dr. Duronio’s Lab • PeymanHojabrpour - Dr. Ghahry’s Lab

  14. Thanks for Your Attention

  15. Collagen Synthesis Always cleave up your mess; William McKleroyet al. A J Physiology - Lung Cellular and Molecular Physiology. Published 1 June 2013Vol. 304

More Related